You are here: Industry Insights > Autolus

News List

PPF Expands its Investment in the Healthcare Sector Through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics b3cnewswire
September 17, 2019
PPF announces the acquisition of a 19.2% stake in Autolus Therapeutics plc, a leader in next-generation T cell programming technologies. The shares were acquired in the market through NASDAQ.
Autolus taps Vineti to help deliver personalized cell therapies fiercebiotech
February 26, 2019
Autolus has a lot of CAR-T candidates heading for clinical trials and has teamed up with software company Vineti to try to bring them to market more efficiently....
Autolus Therapeutics Announces Update on its Novel CAR T Cell Program for Peripheral T Cell Lymphoma (PTCL) pharmafocusasia
December 03, 2018
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer......
AbCellera Collaborates with Autolus on Antibody Discovery Project pharmafocusasia
November 30, 2018
AbCellera announced today its collaboration with Autolus Therapeutics plc (Autolus), a clinical stage biopharmaceutical company developing next-generation programmed T cell therapies.....
IPO bonanza continues with $150M listing for CAR-T player Autolus fiercebiotech
June 25, 2018
Biotech IPOs continue to come thick and fast this week, with U.K. T-cell therapy specialist Autolus the latest to list with an impressive $150 million raise.
Early Thoughts On Autolus IPO newsnow
May 14, 2018
Autolus Therapeutics, a small British biotech company, has filed to go public.